Joanne Hojsak, MD is an associate professor of pediatrics at Mount Sinai School of Medicine and a board-certified pediatric intensivist at Mount Sinai Kravis Children’s Hospital. Dr. Hojsak is the medical director of the Pediatric Intensive Care Unit (PICU) and chief of the division of Pediatric Critical Care Medicine since 2006. Dr. Hojsak is involved in direct patient care in the PICU for six months per year, and initiated patient and family-centered rounds in the PICU in 2009. These PICU rounds have demonstrated the feasibility of incorporating families in daily work rounds and exemplified the benefits in patient care and satisfaction.
Dr.Hojsak is also director of the Pediatric Pain Team, a care team that she initiated in 2002. Since January 2009, Dr. Hojsak has participated in the Clinical Quality Fellowship Program, developed by the Greater New York Hospital Association and the United Hospital Fund. With GNYHA/UHF guidance, Dr. Hojsak is studying methods by which to improve inpatient pediatric pain management. The Pediatric Pain Quality Initiative was started with the mission of empowering patients and families to discuss and participate in their pain management and to develop a more efficient mechanism by which to receive treatment for pain. Dr. Hojsak is also a member of the Pediatric Advanced Care and Comfort Team (PACCT), and supports patients with life-threatening illnesses and their families.
In 2003, Dr. Hojsak became a faculty member for the Art and Science of Medicine I, a year-long course for first year medical students, designed to teach the incorporation of professionalism into patient history-taking, physical examination, daily clinical encounters and research endeavors. In July 2009 she was appointed Course Director for ASM I and is participating in medical school curriculum innovation. Dr. Hojsak is active in pediatric resident education and lectures on a variety of critical care topics, as well as pediatric pain control. Throughout her career, Dr. Hojsak has been granted several teaching awards, including the 2004 “Excellence in Teaching” award, given by the Institute for Medical Education at Mount Sinai School of Medicine.
Pediatric Critical Care Medicine
American Board of Pediatrics
MD, Mount Sinai School of Medicine
Mount Sinai Hospital
Fellowship, Peds/Crtical Care
Texas Children's Hospital
Klein GW, Hojsak JM, Rapaport R. Hyperglycemia in the pediatric intensive care unit. Curr Opin Clin Nutr Metab Care 2007; 10: 187-192.
Feierman D, Yudkowitz FS, Hojsak J, Emre S. Management of a cadaveric orthotopic liver transplantation in a pediatric patient with complex heart disease. Pediatric Anesthesia 2006; 16: 669-675.
Emre S, Schwartz ME, Shneider B, Hojsak J, Kim-Shluger L, Fishbein TM, Guy SR, Sheiner PA, LeLeiko NS, Birnbaum A, Suchy FJ, Miller CM, . Living related liver transplantation for acute liver failure in children. Liver Transplantation and Surgery 1999 May; 5(3): 161-165.
Hojsak J, Mansfield RT, Ting A. Pediatric Critical Care/Pulmonology. In: Lembo RM, editor. Educational Review Manual in Pediatrics Fifth edition. New York, Castle Connolly Graduate Medical Publishing LLC;.
Bowlby D, Hojsak J, Rapaport R, . Persistent Hyperglycemia in Critically Ill Children. J Pediatr 2006 Jun; 148(6): 847.
Kattan M, Hojsak JM. Treatment of acute life-threatening asthma in children. In: The Pediatric Lung. Switzerland, Birkauser Verlag; pp137-153.
Hojsak JM, Shneider B, Emre S, E. Course and outcome of fulminant hepatic failure in children [abstract]. Pediatr Crit Care Med . 2003; 4:. (Suppl.) A.
Hojsak JM, Kattan M, Siegel L, Mansfield R, Ting A. Albumin vs. normal saline as replacement fluid in pediatric liver transplant recipients [abstract]. Pediatri Crit Care Med . 2003; 4:. Suppl A186.
Klein G, Hojsak J, Hyman S, Rapaport R. Hyperglycemia on admission to the pediatric intensive care unit: Frequency and association with patient outcome.;.
Hojsak J. The critically ill child with an infection. Auto-Digest Pediatrics 2003 September 7; 49(17).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Hojsak did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.